Tips For Social Distancing, Quarantine, And Isolation During An Infectious Disease Outbreak

Emergency Grants to Address Mental and Substance Use Disorders During COVID-19 SAMHSA is accepting applications for Emergency Grants to Address Mental and Substance Use Disorders During COVID-19 (Emergency COVID-19). The purpose of this program is to provide crisis intervention services, mental and substance use disorder treatment, crisis counseling, and other related supports for children and adults impacted by the COVID-19 pandemic. Funding will be provided for states, territories, and tribes to develop comprehensive systems to address these needs. The purpose of this program is specifically to address the needs of individuals with serious mental illness, individuals with substance use disorders, and/or individuals with co-occurring serious mental illness and substance use disorders. SAMHSA plans to issue 60 grants of up to $2 million per State or up to $500,000 for Territories and Tribes for 16 months. Application Due Date: Friday, April 10, 2020   Tips For Social Distancing, Quarantine, And Isolation During An Infectious Disease Outbreak Training and Technical Assistance Related to COVID-19 SAMHSA’s training, and technical assistance centers provide tools and resources to practitioners in the fields of mental health and substance use disorders.

Considerations for the Care and Treatment of Mental and Substance Use Disorders in the COVID-19 Epidemic: March 20, 2020   This guidance offers considerations aimed at decreasing the likelihood of infection and viral transmission and providing for the behavioral health needs of patients.

Considerations for Crisis Centers and Clinicians in Managing the Treatment of Alcohol or Benzodiazepine Withdrawal during the COVID-19 Epidemic: March 19, 2020  The COVID-19 crisis has created an additional concern for those with alcohol use disorder, benzodiazepine use disorder, or other conditions that increase the risk of seizures.

Considerations for Outpatient Mental and Substance Use Disorder Treatment Settings  Persons with Serious Mental Illness that are served in outpatient treatment settings may be at elevated risk for acquiring Covid-19 and may have a more complicated course.  The Centers for Disease Control and Prevention (CDC) gives some specific guidance for outpatient facilities during the Covid19 emergency.

COVID-19: Interim Considerations for State Psychiatric Hospitals In contrast to general healthcare settings, psychiatric facilities may have unique challenges in prevention and infection control for several reasons.

Your Recovery is Important: Virtual Recovery Resources This tip sheet describes resources that can be used to support recovery virtually from mental/substance use disorders. It also provides resources to help local recovery programs create virtual meetings.

Emergency Situations: Preparedness, Planning, and Response The Privacy Rule protects individually identifiable health information from unauthorized or impermissible uses and disclosures. This guidance addresses the release of protected health information for planning or response activities in emergency situations.

DEA Information on Telemedicine While a prescription for a controlled substance issued by means of the Internet (including telemedicine) must generally be predicated on an in-person medical evaluation (21 U.S.C. 829(e)), the Controlled Substances Act contains certain exceptions to this requirement.

DEA Diversion Control COVID-19 Information Page The mission of Drug Enforcement Administrations (DEA), Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.

Stay Up-To-Date Coronavirus.gov Coronavirus Disease 2019 (COVID-19) What the U.S. Government is Doing